Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WMLP +150%, that's why you DD, link back
TEVA more information: red flags: cash flow Q2 only $162m, very low, $30B debt. Company can't rely on Copaxone anymore. This is over ( net sale decreased by 46%).
$FB Despite the record-breaking loss, Facebook's current price is still above its share prices just a few months ago.
Thank you. Those who following me know I'm stick to facts only and never invest if financial ratios don't meet my minimal requierments..that's my agenda, and if I include also any assumptions, always backup w/ logical perspective and experience such as market needs, market space and more. I'm usually very conservative .
ANIA77, CVSI thank you for sharing this solid information
BOSC I have researched a lot. here the proof. Amazing solid undervalued Gem https://globenewswire.com/news-release/2018/08/02/1546399/0/en/B-O-S-Featured-as-July-2018-Company-of-the-Month-in-The-Bowser-Report-Investor-Newsletter.html
Just pointed that stock market could easily lose it's mojo at some point.
They just getting started or will be joined post a buy-out which might be at several times it's current MC. Just Re-read recent developments, expanding the entire world.on such a solid balance sheet and the small tradable shares, I can clearly see the reward here.
China says it must retaliate against tariffs 'to defend the nation's dignity'
Cnbc reported
TEVA $241M net lose ( GAAP). gross profit reduced sharply, By 27%. Another red flag is TEVA's flag product Copaxone. Sales collapsed by 46%. I recommended it at around $17, but recently warned about it's future: ash: "TEVA Bonds - real concern. Moody’s Downgrades Teva Bond Rating to “Junk”. Teva’s Credit Rating also Cut to Junk by Fitch".
$20/sh my traget here.
BKYI news. A Leading Latin America Telecom Provider, Selects BIO-key Biometric Software to Secure Access to Customer Data.
Expanding very fast these days a buy out coming.see my DD.
$BKYI BIO-key Partners With Aluratek, Expanding Retail Availability of TouchLock https://t.co/9FkibXgYwQ $20m cap likely to be $200m post a possible buy-out. 2 new patents fits $AAPL $FB $TWTR Needs these days #Japan also going craxy. New office just openned there. 2.5m float.zero dilution. $BKYI "there are no longer any issued and outstanding shares of Series A-1 Preferred" Since May 31, 2018 8-k. (converted at $3.6/sh). company got rid of all preferred stock, which reduced Dividends costs and total expenses. Company announcement which eliminated approximately $638,000 in future annual preferred stock dividends payments. That's a very strong commitment.
Very cheap here. Won't last for long.
Same here
One of well known shorts weapon is the send irrelevant information to multiple Recipients. So do your DD. It doesn't works. CEI is way undervalued here
Shorts trying.no success. Heading higher after hours
OPK Defiantly a nice golden cross per chart
nice plan.
there is also no dilution and no more A-1 Preferred stock . On May 31, 2018, BIO-key International, Inc. (the “ Company ”, “ we ” or “ us ”) received a conversion notice from Wong Kwok Fong to convert 23,508 shares of the Company’s Series A-1 Convertible Preferred Stock (the “ Series A -1 Preferred ”). Each share of Series A-1 Preferred has an original issue price of $100.00 and is convertible into shares of Company common stock (“ Common Stock ”) at a conversion price of $3.60 per share. The forgoing conversion resulted in the issuance of 653,000 shares of Common Stock. As a result of the forgoing conversion, there are no longer any issued and outstanding shares of Series A-1 Preferred.
company got rid of all preferred stock, which reduced Dividends costs and total expenses. Company announcement which eliminated approximately $638,000 in future annual preferred stock dividends payments. That's a very strong commitment.
the owner already holds 9.99% per 13g filing beside he can not sell.
at least volume picking up.
CEI the bullish pattern is just Re-Confirmed. trading strong here
I'm sorry about that, but you still holding and buying because you know the potential and holding for the long term as i'm.
The bullish pattern is just Re-Confirmed (above MA50). I'm sure no one will try to short this again anytime soon post past days action.
Trading at at least 80% discount right now per insiders estimation. Current price represents nothing due the low volume.
Shorts should cover asap. Q2 2018
QUARTER ENDED SEP 30, 2017
Should be out around mid-Movember if I got it right and if commodities prices will remain at today's level, revenues should almost 2X the revenues reported at Q1 + a Debt-free status will be reflected as well.
$BP #OIL #Crude BP profits soar on buoyant oil market https://t.co/xo0ht9EH10 actually upcoming earnings should be very good to most oil&gas companies due to current prices are almost 2X the revenues reported in Q1 2018
#oil companies such as $TGC $CEI will enjoy it most due to the solid balance sheet,low float and and tiny MC.
$BKYI Vendetti wrote: "The company maintained its full-year revenue guidance of $8M-$12M. Introducing 2020 estimates with revenue of $26.6M and GAAP EPS of $0.26.”
Alex Perala recently wrote (MobiellDWorld.com) ."the first part of 2018, with BIO-key having seen orders from across the government, manufacturing, and banking sectors".Biometric hottest sector. market potential is all sectors you can imagine. Gov, Banking, Mobile...
Exactly.my guess is close to $12m rather than $8
I agree. About 2.5m float here if I got it right so it's easy to manipulate.
Usually when a stock heading down on a very low volume it just a but opp. to me
A good plan. I did the same.
Doesn't make any sense why it's trading down at these levels while Company maintained a full year revenue guidance in the range of $8M - $12M.
BKYI Doesn't make any sense why it's trading down at these levels while Company maintained a full year revenue guidance in the range of $8M - $12M.
Agree.
No more Preferred stock. Company converted All recently at $3.6/sh.
$CEI Q2 2018
QUARTER ENDED SEP 30, 2017
Should be out around mid-Movember if I got it right and if commodities prices will remain at today's level, revenues should almost 2X the revenues reported at Q1 + a Debt-free status will be reflected as well.
RKDA ran from $4 to $50 post a few millions debt tecuction ( I alerted it here).CEI eliminated total debt ( about $41m). BTW. $YTEN also reduced debt sharply to almost a zero. Has strong cash on hand ( until Mid-2019), several Catalysts. UAVS debt reduced by 70% too.
DRYS as expected. Another net income. And book value is over $9/sh. Basically that's a good report.
Think different . Wow
Loosing my patience here
CEI .41 above MA50 https://stockcharts.com/h-sc/ui?s=CEI
CEI today's commodities valuation is almost 2X the revenues reported in the 3/31/2018. Per earnings trend company about to report millions in net income, if you ask me. Company is a completely debt-Free, means also profit margin will be surged